911396-25-3Relevant academic research and scientific papers
SUBSTITUTED ARYLOXOETHYL CYCLOPROPANECARBOXAMIDE COMPOUNDS AS VR1 RECEPTOR ANTAGONISTS
-
Page/Page column 33, (2010/11/24)
This invention provides a compound of the formula (I): (I) These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor, such as pain, or the like in mammalian. This invention also provides a pharmaceutic
ARYL OR HETEROARYL CARBONYL DERIVATIVES DERIVATIVES USEFUL AS VANILLOID RECEPTOR 1 (VR1) ANTAGONISTS
-
Page/Page column 39, (2010/10/20)
This invention provides a compound of the formula (I): wherein R1 and R2 independently represent hydrogen or (C1-C6)alkyl or the like; R3 and R4 independently represent hydrogen or (C1
